Kenji Tsuchida Selected Research

Neoplasms (Cancer)

10/2011	[A case of malignant tumor of the ascending part of duodenum with osteoclast-like giant cells].
10/2005	[Relationship between cyclooxygenase (COX)-2 and malignant tumors].
7/2005	5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
6/2004	The effects of cyclooxygenase-2 inhibitors on urological cancer cells.
5/2004	Lipoxygenase inhibitors prevent urological cancer cell growth.
4/2004	Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
3/2004	Relationship between lipoxygenase and human testicular cancer.
2/2004	Study of cyclooxygenase-2 in renal cell carcinoma.
1/2004	Expression of 12-lipoxygenase in human renal cell carcinoma and growth prevention by its inhibitor.
12/2003	The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenji Tsuchida Research Topics

Disease

11	Neoplasms (Cancer) 10/2011 - 11/2003
4	Renal Cell Carcinoma (Grawitz Tumor) 07/2005 - 12/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2016 - 06/2005
3	Infections 12/2015 - 11/2015
3	Myocardial Infarction 01/2014 - 03/2003
3	Peritoneal Fibrosis 12/2007 - 01/2005
3	Urologic Neoplasms (Urological Cancer) 06/2004 - 12/2003
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2016
2	Vascular Calcification 04/2016 - 12/2013
2	Peritonitis 12/2015 - 12/2007
2	Arteriovenous Fistula 11/2015 - 11/2015
2	Amyloidosis 02/2013 - 01/2011
2	Inflammation (Inflammations) 02/2013 - 01/2005
2	Anemia 01/2011 - 06/2007
2	Disease Progression 02/2006 - 10/2002
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 02/2006 - 10/2002
2	Neoplasm Metastasis (Metastasis) 01/2004 - 11/2003
2	Carcinoma (Carcinomatosis) 12/2003 - 11/2003
2	Urinary Bladder Neoplasms (Bladder Cancer) 12/2003 - 11/2003
1	Lymphatic Metastasis 01/2022
1	Gastroesophageal Reflux (GERD) 07/2016
1	Non-Erosive Reflux Disease 07/2016
1	Sleep Wake Disorders 07/2016
1	Chronic Renal Insufficiency 12/2015
1	Pain (Aches) 11/2015
1	Hepatocellular Carcinoma (Hepatoma) 03/2014
1	Hemorrhagic Stroke 01/2014
1	Ischemic Stroke 01/2014
1	Stroke (Strokes) 01/2014
1	Osteoarthritis 01/2011
1	Pruritus (Itching) 01/2011
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2007
1	Critical Illness (Critically Ill) 02/2006
1	Sepsis (Septicemia) 02/2006
1	Carcinogenesis 10/2005
1	Colorectal Neoplasms (Colorectal Cancer) 10/2005
1	Fibrosis (Cirrhosis) 06/2005
1	Cerebral Infarction 06/2005
1	Prostatic Neoplasms (Prostate Cancer) 04/2004
1	Testicular Neoplasms (Testicular Cancer) 03/2004
1	Cystitis 11/2003

Drug/Important Bio-Agent (IBA)

8	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2005 - 11/2003
6	Lipoxygenase (Lipoxygenase-1)IBA 07/2005 - 11/2003
6	Arachidonic Acid (Vitamin F)IBA 07/2005 - 11/2003
4	CytokinesIBA 01/2011 - 10/2002
4	EicosanoidsIBA 04/2004 - 11/2003
3	Dialysis SolutionsIBA 12/2015 - 01/2005
3	Proteins (Proteins, Gene)FDA Link 03/2014 - 01/2011
3	Lipoxygenase InhibitorsIBA 07/2005 - 11/2003
2	AlbuminsIBA 09/2016 - 01/2005
2	MineralsIBA 04/2016 - 01/2014
2	Peptides (Polypeptides)IBA 03/2014 - 02/2004
2	Interleukin-6 (Interleukin 6)IBA 02/2006 - 01/2005
2	EnzymesIBA 10/2005 - 06/2004
2	Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA 01/2004 - 11/2003
1	NivolumabIBA 01/2022
1	mercaptoalbuminIBA 09/2016
1	Proton Pump InhibitorsIBA 07/2016
1	Trastuzumab (Herceptin)FDA Link 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	HematinicsIBA 12/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2015
1	Local Anti-Infective Agents (Antiseptics)IBA 11/2015
1	gadolinium ethoxybenzyl DTPA FDA Link 03/2014
1	GadoliniumIBA 03/2014
1	Pentetic Acid (DTPA)FDA LinkGeneric 03/2014
1	AnionsIBA 03/2014
1	CalciumIBA 01/2014
1	Phosphates (Orthophosphate)IBA 01/2014
1	Matrix Gla ProteinIBA 12/2013
1	Amyloid (Amyloid Fibrils)IBA 02/2013
1	VimentinIBA 10/2011
1	Complement Factor D (Factor D)IBA 01/2011
1	HomocysteineIBA 01/2011
1	Interleukin-8 (Interleukin 8)IBA 02/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2006
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2006
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2005
1	Glucose (Dextrose)FDA LinkGeneric 06/2005
1	Messenger RNA (mRNA)IBA 06/2005
1	Connective Tissue Growth FactorIBA 06/2005
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2005
1	Fibrinogen (Factor I)FDA Link 01/2005
1	Immunoglobulin G (IgG)IBA 01/2005
1	Fibrin Fibrinogen Degradation ProductsIBA 01/2005
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2004
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2004
1	LigandsIBA 12/2003
1	PPAR gammaIBA 12/2003

Therapy/Procedure

11	Renal Dialysis (Hemodialysis) 04/2016 - 01/2003
8	Therapeutics 01/2022 - 11/2002
4	Peritoneal Dialysis 12/2015 - 01/2005
4	Hemoperfusion 02/2013 - 10/2002
3	Catheters 12/2015 - 03/2003
1	Drug Therapy (Chemotherapy) 01/2022
1	Hemodiafiltration 12/2015
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 06/2005